Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Uniseed is Australia's longest-running venture capital fund, established to help researchers commercialize their innovations. Based in Australia, it collaborates with partner research organizations and UniSuper, a prominent superannuation fund. The firm has multiple funds, including its largest fund launched in 2015, backed by several universities and research institutions.
Uniseed invests in seed-stage companies across biotech, healthcare, and SaaS sectors. The firm provides seed capital to researchers and startups, emphasizing collaboration and expert guidance to mitigate technical and commercial risks. Their investment strategy includes syndicating promising deals with co-investors to support the growth of innovations.
Uniseed has notable exits including Fibrotech, Spinifex, and Hatchtech. The firm has also supported companies like Q-Sera, which developed the RAPClot™ rapid serum blood collection tube technology, and ENA Respiratory, known for the INNA-051 nasal spray for viral respiratory infections.
Submit your pitch through their website's contact form.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.